A Step Closer
We won’t claim victory just yet but another prediction we made just became more of a possibility with Insulet acquiring patents from Bigfoot Biomedical.
“Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, and Bigfoot Biomedical (Bigfoot), a leader in developing intelligent connected injection support systems, today announced Insulet has acquired assets related to Bigfoot’s pump-based automated insulin delivery (AID) technologies. Insulet paid $25M for the acquisition, which includes certain Bigfoot patents related to pumps that may be used for AID therapy.”
This move is interesting not . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.